bendamustine hydrochloride has been researched along with Obesity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Sawaf, O; Cramer, P; Döhner, H; Dreyling, M; Eichhorst, B; Fink, AM; Fischer, K; Fürstenau, M; Goede, V; Hallek, M; Hensel, M; Hoechstetter, M; Hopfinger, G; Jaeger, U; Kiehl, MG; Kneba, M; Kutsch, N; Lange, E; Langerbeins, P; Maurer, C; Robrecht, S; Stilgenbauer, S; Theurich, S; Tresckow, JV; von Bergwelt-Baildon, M; Wendtner, CM | 1 |
1 other study(ies) available for bendamustine hydrochloride and Obesity
| Article | Year |
|---|---|
Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Clinical Trials, Phase III as Topic; Female; Follow-Up Studies; Humans; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Obesity; Prognosis; Prospective Studies; Rituximab; Sex Factors; Survival Rate; Vidarabine | 2020 |